Table 2. Levodopa encapsulation efficiencies (EE), percent lipid recoveries, and percent levodopa loadings of PEGylated and targeted liposome groups prepared at 40 °C.

Liposome groups	% EE	% lipid recovery	% drug loading
(2%) PEG/LUV	71.60 ± 0.65	47.77 ± 0.37	36.92 ± 0.33
(4%) PEG/LUV	74.57 ± 1.04	49.05 ± 0.18	38.01 ± 0.63
(0.35%) MD-(4%) PEG/LUV	71.38 ± 0.21	52.46 ± 0.19	33.68 ± 0.49
(0.7%) MD-(4%) PEG/LUV	92.47 ± 2.70	52.24 ± 0.19	44.25 ± 0.33
(20 μM) GSH-(0.7%) MD-(4%) PEG/LUV	72.88 ± 0.60	50.13 ± 0.17	36.34 ± 0.17
(40 μM) GSH-(0.7%) MD-(4%) PEG/LUV	83.76 ± 2.57	51.16 ± 0.17	40.93 ± 1.39